Sign in
CompletedNo phase

Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

Key facts

Who runs it
AbbVie
Where
China4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
17 Jul 2025
Ended
13 Nov 2025
Type of study
Observational
Record updated
19 November 2025

Who can take part

Age
12 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Male and female patients, age ≥ 12
  • Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI<50) with or without facial involvement
  • Medical history available within the last 6 months
  • Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and < 18 years of age at inclusion visit)
  • Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable

Who cannot take part

  • Patients who are currently receiving treatment with any investigational drug/device/intervention or have received any investigational product within 1 month or 5 half-lives of the investigational agent (whichever is longer) prior to enrollment
  • History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo
  • Unable or unwilling to comply with study requirements and electronic Patient-Reported Outcome (ePRO) collection
  • Segmental or localized vitiligo
  • Greater than 33% leukotrichia in areas of vitiligo on the face or on the body
  • Patients who are participating in interventional clinical trial(s) at time of study visit

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China

Read full original descriptionShow less

This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
19 November 2025